Want to see SSII full AI Analyst Report?
SSII Stock Chart & Stats
$3.83
$0.03(0.80%)
At close: 4:00 PM EDT
$3.83
$0.03(0.80%)
Day’s Range― - ―
52-Week Range$3.11 - $10.00
Previous Close$3.95
Volume11.27K
Average Volume (3M)65.98K
Market Cap
$779.50M
Enterprise Value$826.14
Total Cash (Recent Filing)$13.65M
Total Debt (Recent Filing)$3.24M
Price to Earnings (P/E)―
Beta9.04
Next Earnings
Nov 03, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding200,385,440
10 Day Avg. Volume79,777
30 Day Avg. Volume65,982
Financial Highlights & Ratios
PEG Ratio2.12
Price to Book (P/B)28.24
Price to Sales (P/S)25.40
P/FCF Ratio-48.61
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$7.00Price Target Upside82.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)$59.00M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRevenue has expanded substantially over two years, indicating stronger system placements and procedure-related demand. Sustained growth can improve operating leverage if SSII converts its expanding commercial footprint into recurring instrument, service, and upgrade revenue.
Expanding Robotics AdoptionA growing installed base, international presence, and increasing procedure volume strengthen clinical credibility and create a foundation for recurring consumables and service revenue. Broader surgeon training and platform use may also support durable adoption across specialties.
Improved Balance-Sheet LeverageThe sharp reduction in leverage and larger equity base improve financial resilience relative to prior years. Lower debt exposure reduces refinancing and solvency risk, giving SSII more flexibility to fund commercialization while its business scales.
Bears Say
Persistent UnprofitabilityDespite strong revenue growth and modest gross-margin improvement, SSII continues to report substantial operating and net losses. The company has not yet demonstrated that its sales expansion can produce sustainable earnings after commercial, operating, and development costs.
Negative Operating Cash FlowOngoing operating and free-cash-flow deficits mean SSII is not yet funding growth internally. Persistent cash burn increases dependence on external financing and could constrain investment or dilute shareholders if profitability and cash conversion do not improve.
Equity Financing And Dilution RiskThe ATM program expands access to capital, but potential share issuance can dilute existing ownership. Given persistent losses and negative free cash flow, recurring reliance on equity markets may remain a structural funding risk until operations approach self-sufficiency.
SS Innovations International News
SSII FAQ
What was SS Innovations International’s price range in the past 12 months?
SS Innovations International lowest stock price was $3.11 and its highest was $10.00 in the past 12 months.
What is SS Innovations International’s market cap?
SS Innovations International’s market cap is $779.50M.
When is SS Innovations International’s upcoming earnings report date?
SS Innovations International’s upcoming earnings report date is Nov 03, 2026 which is in 78 days.
How were SS Innovations International’s earnings last quarter?
SS Innovations International released its earnings results on Aug 13, 2026. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.
Is SS Innovations International overvalued?
According to Wall Street analysts SS Innovations International’s price is currently Undervalued.
Does SS Innovations International pay dividends?
SS Innovations International does not currently pay dividends.
What is SS Innovations International’s EPS estimate?
SS Innovations International’s EPS estimate is -0.01.
How many shares outstanding does SS Innovations International have?
SS Innovations International has 200,385,440 shares outstanding.
What happened to SS Innovations International’s price movement after its last earnings report?
SS Innovations International reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went up 3.794%.
Which hedge fund is a major shareholder of SS Innovations International?
Currently, no hedge funds are holding shares in SSII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS Innovations International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (82.77% Upside)
$7.00 (82.77% Upside)
Blogger Sentiment
Bullish
SSII Sentiment 100%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.84%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
42.69%
Trailing 12-Months
Company Description
SS Innovations International
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
SSII Stock 12 Month Forecast
Average Price Target
$7.00
▲(82.77% Upside)
Technical Analysis
Ownership Overview
67.58% Insiders
0.46% Mutual Funds
0.74% Other Institutional Investors
31.12% Public Companies and
Individual Investors